Stocks › MDLZ
Mondelez International MDLZ
US equityMarket cap rank #249
$66.28 +$0.59 (+0.90%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $66.60 +0.48%
Open$66.53
Prev close$65.69
Day range$66.08 – $67.39
Volume12.07M
Market cap$83.90B
P/E (TTM)20.8
Dividend yield3.05%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$9.97B+2.3% YoY
Operating profit$1.89B+140.3% YoY
Net profit$1.31B+75.3% YoY
Diluted EPS$1.02+78.9% YoY
Free cash flow$991.00M+137.1% YoY
Operating cash flow$1.28B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin34.3%
Operating margin14.2%
Net margin10.2%
Return on equity15.5%
Return on assets5.7%
Return on invested capital9.3%
Current ratio0.62
Liabilities / assets62.9%
Cash & investments$1.63B
Total debt$22.33B
Net cash (debt)-$20.71B
Free cash flow / sales9.2%
Where the revenue comes from
Quarter 2026/Q3
By business line
SEC annual financial snapshot
Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-21 15:51 UTC.
| Metric | USD | Basis | Period end | Filed / SEC source |
|---|---|---|---|---|
| Revenue | $38.54B | Annual | 2025-12-31 | 2026-02-04 |
| Net income | $2.45B | Annual | 2025-12-31 | 2026-02-04 |
| Operating cash flow | $4.51B | Annual | 2025-12-31 | 2026-02-04 |
| Total assets | $71.49B | Period end | 2025-12-31 | 2026-02-04 |
| Total liabilities | $45.60B | Period end | 2025-12-31 | 2026-02-04 |
| Stockholders’ equity | $25.84B | Period end | 2025-12-31 | 2026-02-04 |
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $9.97B | $9.36B | $10.08B | $38.54B | $10.50B |
| Total Operating Revenue | $9.97B | $9.36B | $10.08B | $38.54B | $10.50B |
| Cost of Revenue | $6.04B | $5.37B | $7.28B | $27.60B | $7.54B |
| Gross Profit | $3.92B | $3.99B | $2.80B | $10.94B | $2.96B |
| Operating Expense | $2.04B | $2.03B | $1.94B | $7.32B | $1.98B |
| Selling and Admin Expenses | $2.01B | $2.00B | $1.92B | $7.17B | $1.94B |
| Depreciation & Amortization & Depletion | $26.00M | $26.00M | $27.00M | $142.00M | $35.00M |
| -Depreciation & Amortization | $26.00M | $26.00M | $27.00M | $142.00M | $35.00M |
| Operating Profit | $1.89B | $1.96B | $860.00M | $3.62B | $979.00M |
| Net Non-Operating Interest Income (Expense) | -$147.00M | -$74.00M | -$148.00M | -$282.00M | $163.00M |
| Non-Operating Interest Expense | $147.00M | $144.00M | $148.00M | $599.00M | $154.00M |
| Other Income (Expense) | -$18.00M | $14.00M | $63.00M | -$324.00M | -$223.00M |
| Special Income (Charges) | -$128.00M | -$13.00M | -$52.00M | -$72.00M | -$27.00M |
| -Less:Write Off | $128.00M | $13.00M | $53.00M | $85.00M | $40.00M |
| -Gain on Sale Of Business | $0.00 | $0.00 | $1.00M | – | – |
| Other Non-Operating Income (Expenses) | $110.00M | $27.00M | $115.00M | -$252.00M | -$196.00M |
| Pretax Profit | $1.72B | $1.90B | $775.00M | $3.01B | $919.00M |
| Tax | $424.00M | $364.00M | $228.00M | $782.00M | $261.00M |
| -$11.00M | -$17.00M | -$17.00M | -$234.00M | -$11.00M | |
| Net Profit | $1.31B | $1.55B | $564.00M | $2.47B | $669.00M |
| Profit from Continuing Operations | $1.31B | $1.55B | $564.00M | $2.47B | $669.00M |
| Minority Interests | $3.00M | $4.00M | $4.00M | $15.00M | $4.00M |
| Net Income to Parent Company | $1.31B | $1.55B | $560.00M | $2.45B | $665.00M |
| Net Income to Common Stockholders | $1.31B | $1.55B | $560.00M | $2.45B | $665.00M |
| Basic EPS | $1.02 | $1.21 | $0.44 | $1.89 | $0.52 |
| Diluted EPS | $1.02 | $1.20 | $0.44 | $1.89 | $0.51 |
| Dividend Per Share | $0.52 | $0.50 | $0.50 | $1.94 | $0.50 |
| Non-Operating Interest Income | – | $70.00M | – | $317.00M | – |
| -Less:Impairment of Capital Assets | – | $13.00M | $53.00M | $85.00M | $40.00M |
| -Less:Restructuring and Mergern & Acquisition | – | – | – | -$13.00M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $71.78B | $71.25B | $71.12B | $71.49B | $71.49B |
| Total Current Assets | $13.79B | $12.94B | $12.75B | $12.95B | $12.95B |
| Cash and Cash Equivalents & Short-Term Investments | $1.63B | $1.72B | $1.52B | $2.13B | $2.13B |
| -Cash and Cash Equivalents | $1.63B | $1.72B | $1.52B | $2.13B | $2.13B |
| Receivables | $5.87B | $5.01B | $5.38B | $4.86B | $4.86B |
| -Accounts Receivable | $4.92B | $4.01B | $4.40B | $3.90B | $3.90B |
| -Other Receivables | $955.00M | $998.00M | $985.00M | $955.00M | $955.00M |
| Inventory | $4.44B | $4.41B | $4.08B | $4.42B | $4.42B |
| Other Current Assets | $1.85B | $1.81B | $1.76B | $1.55B | $1.55B |
| Total Non-Current Assets | $57.99B | $58.31B | $58.38B | $58.54B | $58.54B |
| Net PPE | $11.36B | $11.38B | $11.29B | $11.40B | $11.40B |
| -Gross PPE | $21.12B | $21.07B | $20.77B | $20.79B | $20.79B |
| -Accumulated Depreciation | -$9.76B | -$9.69B | -$9.48B | -$9.40B | -$9.40B |
| Investments and Advances | $694.00M | $619.00M | $610.00M | $667.00M | $667.00M |
| -Long Term Equity Investment | $694.00M | $619.00M | $610.00M | $667.00M | $667.00M |
| Goodwill and Other Intangible Assets | $43.37B | $43.69B | $43.76B | $43.96B | $43.96B |
| -Goodwill | $24.03B | $24.18B | $24.23B | $24.34B | $24.34B |
| -Other Intangible Assets | $19.35B | $19.51B | $19.53B | $19.63B | $19.63B |
| Defined Pension Benefit | $1.28B | $1.25B | $1.26B | $1.22B | $1.22B |
| Non-Current Deferred Assets | $82.00M | $184.00M | $316.00M | $336.00M | $336.00M |
| Other Non-Current Assets | $1.20B | $1.19B | $1.14B | $951.00M | $951.00M |
| Total Liabilities | $45.12B | $44.56B | $45.32B | $45.60B | $45.60B |
| Total Current Liabilities | $22.40B | $21.59B | $23.50B | $21.86B | $21.86B |
| Payables | $9.51B | $9.41B | $9.74B | $10.14B | $10.14B |
| -Accounts Payable | $9.51B | $9.41B | $9.74B | $10.14B | $10.14B |
| Current Accrued Expenses | $2.90B | $2.61B | $2.97B | $2.79B | $2.79B |
| Short-Term Debt and Capital Lease Obligation | $5.39B | $4.99B | $5.56B | $3.98B | $3.98B |
| -Current Debt | $5.39B | $4.99B | $5.56B | $3.98B | $3.98B |
| Other Current Liabilities | $3.57B | $3.71B | $4.37B | $3.96B | $3.96B |
| Total Non-Current Liabilities | $22.72B | $22.96B | $21.82B | $23.73B | $23.73B |
| Long Term Debt and Capital Lease Obligation | $16.94B | $17.07B | $16.07B | $17.82B | $17.82B |
| -Long Term Debt | $16.35B | $16.46B | $15.47B | $17.22B | $17.22B |
| -Long Term Capital Lease Obligation | $591.00M | $609.00M | $598.00M | $599.00M | $599.00M |
| Non-Current Deferred Liabilities | $3.59B | $3.54B | $3.55B | $3.53B | $3.53B |
| Employee Benefits | $424.00M | $442.00M | $461.00M | $496.00M | $496.00M |
| Other Non-Current Liabilities | $1.77B | $1.91B | $1.74B | $1.89B | $1.89B |
| Total Equity | $26.66B | $26.69B | $25.80B | $25.89B | $25.89B |
| Stockholders' Equity | $26.61B | $26.64B | $25.75B | $25.84B | $25.84B |
| Capital Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $32.38B | $32.33B | $32.28B | $32.32B | $32.32B |
| Retained Earnings | $37.88B | $37.23B | $36.33B | $36.41B | $36.41B |
| Less: Treasury Stock | -$32.29B | -$31.64B | -$31.45B | -$31.53B | -$31.53B |
| Gains/Losses Not Affecting Retained Earnings | -$11.36B | -$11.28B | -$11.41B | -$11.36B | -$11.36B |
| Minority Interests | $51.00M | $53.00M | $54.00M | $53.00M | $53.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.28B | $855.00M | $467.00M | $4.51B | $2.40B |
| Net cash flow from continuing operations | $1.28B | $855.00M | $467.00M | $4.51B | $2.40B |
| Net Income from Continuing Operations | $1.31B | $1.55B | $564.00M | $2.47B | $669.00M |
| Gain/Loss from Continuing Operations | -$594.00M | -$783.00M | $239.00M | $1.30B | $194.00M |
| Depreciation & Depletion & Amortization | $347.00M | $350.00M | $343.00M | $1.36B | $352.00M |
| Deferred Tax | $144.00M | $141.00M | $8.00M | $16.00M | $174.00M |
| Other Non-Cash Items | -$72.00M | $42.00M | -$44.00M | $103.00M | $20.00M |
| Change in Working Capital | $28.00M | -$512.00M | -$719.00M | -$974.00M | $928.00M |
| -Change in Receivables | -$788.00M | $304.00M | -$728.00M | $433.00M | $525.00M |
| -Change in Inventory | -$73.00M | -$330.00M | $314.00M | -$253.00M | $714.00M |
| -Change in Payables and Accrued Expense | $165.00M | -$218.00M | -$320.00M | -$145.00M | $14.00M |
| -Change in Other Current Assets | $119.00M | $143.00M | -$1.00M | -$225.00M | -$195.00M |
| -Change in Other Current Liabilities | $648.00M | -$379.00M | $83.00M | -$1.03B | -$123.00M |
| -Change In Other Working Capital | -$43.00M | -$32.00M | -$67.00M | $242.00M | -$7.00M |
| Net cash flow from investing | -$447.00M | -$294.00M | -$422.00M | -$1.20B | -$266.00M |
| Net Cash Flow from Continuing Investing Activities | -$447.00M | -$294.00M | -$422.00M | -$1.20B | -$266.00M |
| Capital Expenditure | -$293.00M | -$342.00M | -$312.00M | -$1.28B | -$398.00M |
| Net PPE Purchase and Sale | $1.00M | $3.00M | $0.00 | $9.00M | $1.00M |
| Net Business Purchase and Sale | $0.00 | -$16.00M | $17.00M | $112.00M | $123.00M |
| Net Investment Purchase and Sale | -$155.00M | $61.00M | -$127.00M | -$38.00M | $8.00M |
| Financing Cash Flow | -$913.00M | -$435.00M | -$604.00M | -$2.76B | -$1.41B |
| Net Cash Flow from Continuing Financing Activities | -$913.00M | -$435.00M | -$604.00M | -$2.76B | -$1.41B |
| Net Issuance Payments Of Debt | $362.00M | $498.00M | -$44.00M | $2.13B | -$255.00M |
| Net Common Stock Issuance | -$633.00M | -$212.00M | $0.00 | -$2.39B | -$492.00M |
| Cash Dividends Paid | -$640.00M | -$643.00M | -$644.00M | -$2.49B | -$645.00M |
| Net Other Financing Charges | -$2.00M | -$78.00M | $84.00M | -$13.00M | -$21.00M |
| Ending Cash Balance | $1.67B | $1.76B | $1.63B | $2.20B | $2.20B |
| Net Change in Cash | -$76.00M | $126.00M | -$559.00M | $559.00M | $718.00M |
| Beginning Cash Balance | $1.76B | $1.63B | $2.20B | $1.40B | $1.47B |
| Effect of Exchange Rate Changes | -$17.00M | $2.00M | -$5.00M | $236.00M | $11.00M |
| Free Cash Flow | $991.00M | $513.00M | $155.00M | $3.24B | $2.00B |
No comments yet — be the first to weigh in on MDLZ.
Sign in to join the discussion.